# Heart Failure With Reduced Ejection Fraction Polypill Implementation Strategy in Sri Lanka

> **NCT06831864** · PHASE1 · COMPLETED · sponsor: **Washington University School of Medicine** · enrollment: 40 (actual)

## Conditions studied

- Heart Failure With Reduced Ejection Fraction

## Interventions

- **DRUG:** HFrEF Polypill
- **OTHER:** Comparator Arm

## Key facts

- **NCT ID:** NCT06831864
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-02-15
- **Primary completion:** 2025-05-05
- **Final completion:** 2025-05-05
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2025-05-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06831864

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06831864, "Heart Failure With Reduced Ejection Fraction Polypill Implementation Strategy in Sri Lanka". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06831864. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*